Review reveals BPC-157's potential as a cytoprotectant in the gastrointestinal tract, suggesting new therapeutic avenues.
No takes yet. Share an insight, caveat, or question.
Michael Whitehouse (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: